Immune Reconstitution in the Patients with Talasemia Major after Hematopoietic Stem Cell Transplantation

Erman B., Adakli Aksoy B.

TURKISH JOURNAL OF IMMUNOLOGY, vol.8, no.3, pp.113-119, 2020 (ESCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 8 Issue: 3
  • Publication Date: 2020
  • Doi Number: 10.25002/tji.2020.1238
  • Journal Name: TURKISH JOURNAL OF IMMUNOLOGY
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, EMBASE, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.113-119
  • Hacettepe University Affiliated: Yes

Abstract

Introduction: Beta-thalaccemia (beta-TM) is one of the most common, autosomal recessive inherited hematologic disorder in the world. Since hematopoietic stem cell transplantation (HSCT) is the only curative treatment, determination of cellular immune reconstitution is crucial for understanding of a successful clinical outcome. Here, we evaluated lymphoid reconstitution in pediatric patients with thalassemia major after stem cell transplantation.